|
Emergency Contraception (ECP): Reducing Unintended Pregnancies Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Emergency Contraception (ECP): Reducing Unintended Pregnancies conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Emergency Contraception (ECP): Reducing Unintended Pregnancies Clinical research trials and Emergency Contraception (ECP): Reducing Unintended Pregnancies healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Emergency Contraception (ECP): Reducing Unintended Pregnancies. Emergency Contraception (ECP): Reducing Unintended Pregnancies Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Emergency Contraception (ECP): Reducing Unintended Pregnancies clinical trial. Test subjects typically receive the most effective healthcare possible for their Emergency Contraception (ECP): Reducing Unintended Pregnancies condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Emergency Contraception (ECP): Reducing Unintended Pregnancies  Emergency Contraception (ECP): Reducing Unintended Pregnancies
Emergency Contraception (ECP): Reducing Unintended Pregnancies
For Condition: Pregnancy,Contraception
Status: Completed
Sponsor(s): National Institute of Child Health and Human Development (NICHD) ,
Synopsis: Emergency contraception is a method of birth control that can be used up to three days after sexual intercourse. Emergency contraceptive pills (ECPs) can be given to a woman before she needs them (advance provision) or when she needs them (emergency provision). This study will compare these two methods of providing ECPs.
Details: ECPs can give women a “second chance” to prevent an unintended pregnancy that might arise because of lack or improper/defective use of contraceptives. By using ECP, a woman can reduce her risk of pregnancy by at least 75%; however, there is little information on what distribution patterns and other factors are most likely to encourage ECP use. This study will compare the use and cost of two ECP distribution patterns: advance provision and emergency provision. It will also identify environmental, situational, and behavioral factors associated with ECP acceptance and use. Participants in this study will be recruited from four family planning clinics in the Philadelphia area and five family planning clinics in the Pittsburgh area. Participants from the Philadelphia clinics will be given ECPs as part of a regular clinic visit (advance provision); participants from the Pittsburgh clinics will be given ECPs on an emergency basis (emergent provision). Each participant will complete a short intake form and will be issued a pager. Participants will be paged every month over an 18-month period as a reminder to respond to a short automated telephone survey on ECP, contraceptives, and pregnancy status. Approximately half of the participants will be randomly selected to participate in in-depth interviews at study entry and Months 9 and 18. Clinic visit data will augment the surveys to verify use of the clinic and contraceptive method and to develop cost data.
Eligibility:
Study Type: Interventional,Prevention,Non-Randomized,Open Label,Active Control,Factorial Assignment,Efficacy Study
Minimum Age/Maximum Age: 15 Years/39 Years
Genders: Female
Protocol Entry Criteria: Inclusion Criteria - Patient at a participating clinic Exclusion Criteria - Pregnant - Medical or surgical procedure preventing pregnancy (e.g., tubal ligation, hysterectomy) - Norplant or IUDs - Desires to become pregnant
Total Enrollment: 1100
Location and Contact Information:
Overall Study Official:
PaulWhittaker, Principal Investigator,
Family Health Council
Pittsburgh, Pennsylvania, 15222
United States
Family Planning Council
Philadelphia, Pennsylvania, 19102
United States
Additional Information:
Study ID Numbers: HD38515;
Study Start Date: June 2001
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00067509
Other Contraception Studies:
1. Fortovase (Saquinavir) Given with Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
2. Maternal glucose measurement in pregnancy using a continuous ambulatory subcutaneous monitor
3. Study for Future Families
4. Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated with Zidovudine
5. Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Related Studies:
Other Contraception Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Emergency Contraception (ECP): Reducing Unintended Pregnancies
|
|
|
|
|
|
|
|
